These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9496572)

  • 1. [Tuberculosis in hemodialysis].
    Zahiri K; Ramdani B; Hachim K; Benghanem MG; Fatihi E; Zaid D
    Nephrologie; 1997; 18(7):303-6. PubMed ID: 9496572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberculosis of the middle ear: a rare extrapulmonary manifestation].
    Schütte W; Berghaus A; Schütte A
    Dtsch Med Wochenschr; 1996 Dec; 121(49):1551. PubMed ID: 8998926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharyngeal tuberculosis: an analytical study and report of 10 cases].
    Kharoubi S
    Rev Laryngol Otol Rhinol (Bord); 1998; 119(3):203-7. PubMed ID: 9770070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis among hemodialysis patients in Dakar, apropos of 2 cases].
    Diouf B; Niang A; Pouye A; Diouf ML; Mbengue M; Ka MM; Moreira-Diop T; Bao O
    Dakar Med; 1998; 43(1):129-31. PubMed ID: 9874594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis after renal transplantation.
    Kaaroud H; Beji S; Boubaker K; Abderrahim E; Ben Hamida F; Ben Abdallah T; El Younsi F; Ben Moussa F; Kheder A
    Transplant Proc; 2007 May; 39(4):1012-3. PubMed ID: 17524877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urogenital tuberculosis. Apropos of 40 cases].
    el Khader K; el Fassi J; Karmouni T; Tazi K; Ibnattya A; Hachimi M; Lakrissa A
    Ann Urol (Paris); 1997; 31(6-7):339-43. PubMed ID: 9509233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data].
    Iukhimenko NV
    Probl Tuberk; 2001; (5):19-22. PubMed ID: 11588952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP; Ebrahim S; Pillay V
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genitourinary tuberculosis in pediatric urological practice.
    Nerli RB; Kamat GV; Alur SB; Koura A; Vikram P; Amarkhed SS
    J Pediatr Urol; 2008 Aug; 4(4):299-303. PubMed ID: 18644534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis presenting as immune thrombocytopenic purpura.
    Spedini P
    Haematologica; 2002 Feb; 87(2):ELT09. PubMed ID: 11836186
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.